US eyes joint production of Johnson and Johnson Covid vaccine in India, in touch with Serum Institute

US eyes joint production of Johnson and Johnson Covid vaccine in India, in touch with Serum Institute

The White House, last month, had said the United States plans to share AstraZeneca covid vaccine’s 60 million doses globally as soon as they become available, and a significant chunk of the stockpile is being expected by India.
Check the source here –Source, Financial Express.

Change Language